Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company

Astellas Pharma Inc clinical trials

The registry lists 983 studies whose lead sponsor is Astellas Pharma Inc or one of 23 companies grouped under it. 40 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 26, 2026.

Keep track of what changes. Save the Astellas Pharma Inc studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed: 826
Terminated: 81
Recruiting: 33
Active, not recruiting: 20
Withdrawn: 12
Not yet recruiting: 5

Phase

Phase 1: 365
Phase 2: 222
Phase 3: 210
Phase 4: 116

Where

United States: 408
Japan: 249
United Kingdom: 182
Germany: 157
France: 145
Canada: 135

Focus areas

Conditions Astellas Pharma Inc leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 28 areas

Carcinoma10 Eczema10 Hyperphosphatemia10 Hyperplasia10

Studies

Recruiting first, then most recently updated. Showing 50 of 983. Browse all 983 →

A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate CancerRecruitingNCT07339267Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid TumorsRecruitingNCT07730021Phase 1/2
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye ConditionsRecruitingNCT07734064Phase 1
Sponsor listed in the registry: Astellas Institute for Regenerative Medicine · First submitted after Astellas Institute for Regenerative Medicine became part of Astellas Pharma Inc
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07140016Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.RecruitingNCT06902545
Sponsor listed in the registry: Astellas Pharma Korea, Inc.
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsRecruitingNCT07287995Phase 1/2
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderRecruitingNCT07475806Phase 2
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric CancerRecruitingNCT07673887Phase 3
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve DamageRecruitingNCT07770685Phase 1/2
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerRecruitingNCT05997615Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV InjectionRecruitingNCT06011954
Sponsor listed in the registry: Astellas Pharma Korea, Inc.
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerRecruitingNCT06901531Phase 3
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D MutationRecruitingNCT07566052Phase 3
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and AdultsRecruitingNCT07425574
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)RecruitingNCT07566156Phase 3
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate CancerRecruitingNCT07783282Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Long-term Follow-up Study in Male Participants With X-linked Myotubular Myopathy Treated With ASP2957Not yet recruitingNCT07876804Phase 1/2
Sponsor listed in the registry: Astellas Gene Therapies · First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
A Study to Track the Safety of Vesomni in Men in South Korea Treated in Routine Clinical Practice for the Urinary Symptoms of Benign Prostatic Hyperplasia (Enlarged Prostate)Not yet recruitingNCT07619105
Sponsor listed in the registry: Astellas Pharma Korea, Inc.
A Study of ASP3082 in Adults With Advanced Solid TumorsRecruitingNCT05382559Phase 1
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsRecruitingNCT07094204Phase 1
A Study to Learn How ASP3082 is Processed in Healthy MenRecruitingNCT07773129Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
Zolbetuximab and Other Cancer Treatments in People With Advanced Gastric or GEJ Cancer in Clinical Practice (RADIANCE)Not yet recruitingNCT07858500
Sponsor listed in the registry: Astellas Pharma Europe Ltd.
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle ConditionRecruitingNCT06581146
Sponsor listed in the registry: Astellas Gene Therapies · First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through MenopauseNot yet recruitingNCT07829653Phase 3
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsRecruitingNCT07488676Phase 1/2
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerRecruitingNCT07409272Phase 3
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric CancerNot yet recruitingNCT07829757Phase 4
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
Akyva First In HumanRecruitingNCT06956209Not applicable
Sponsor listed in the registry: Iota Biosciences, Inc · First submitted after Iota Biosciences, Inc became part of Astellas Pharma Inc
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerRecruitingNCT05365581Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationRecruitingNCT03178149Phase 1
Sponsor listed in the registry: Astellas Institute for Regenerative Medicine · First submitted after Astellas Institute for Regenerative Medicine became part of Astellas Pharma Inc
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerRecruitingNCT07005154Phase 2
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need VentilatorsRecruitingNCT07052929Phase 1/2
Sponsor listed in the registry: Astellas Gene Therapies · First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal CancerRecruitingNCT07024615Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial CancerRecruitingNCT06862219Phase 4
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study of ASP1002 in Adults for Treatment of Solid TumorsRecruitingNCT05719558Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell TherapyEnrolling by invitationNCT03167203Phase 1/2
Sponsor listed in the registry: Astellas Institute for Regenerative Medicine · First submitted after Astellas Institute for Regenerative Medicine became part of Astellas Pharma Inc
A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a StrokeRecruitingNCT07318714Phase 1/2
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical PracticeRecruitingNCT07602530
Sponsor listed in the registry: Astellas Pharma Europe Ltd.
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerRecruitingNCT04729114Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
Early Access Program for ZolbetuximabAvailableNCT06048081
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid TumorsTerminatedNCT06364696Phase 1
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Active, not recruitingNCT04076059Phase 3
Sponsor listed in the registry: Astellas (Beijing) Pharmaceutical R&D Co., Ltd.
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.Active, not recruitingNCT03504397Phase 3
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®CompletedNCT01294020Phase 2
Sponsor listed in the registry: Astellas Pharma Europe Ltd.
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic CancerActive, not recruitingNCT06396091Phase 1
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic CancerActive, not recruitingNCT03816163Phase 2
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney DiseaseActive, not recruitingNCT05970172Phase 3
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyActive, not recruitingNCT02960022Phase 2
Sponsor listed in the registry: Astellas Pharma Global Development, Inc.
A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe DiseaseActive, not recruitingNCT06150820Not applicable
Sponsor listed in the registry: Astellas Gene Therapies · First submitted after Astellas Gene Therapies became part of Astellas Pharma Inc
A Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor TherapyCompletedNCT04995419Phase 2
Sponsor listed in the registry: Astellas Pharma China, Inc.